|
No records
|
|
365 |
Duc N.T.M., Loc L.Q., Alhady S.T.M., Sabir D.M.E., Mai L.N., Dumre S.P., Hassan A.K., Giang T.V., Thach P.N., Truong L.V., Ravikulan R., Raut A., Dayyab F.M., Trang V.T.T., Huy N.T., Imoto A., Dumre R.B., Ranabhat K., Sharma G.N., Habaj N.A., Elnoamany S., Aziz J.M.A., Crispino K.T., Alsuwiyah S., Hussein R.M., Hama D.J., Morena G.J.V., Aritonang R.S., Rocha I.C.N., Pavlenko D., Kareem H.F.H., Antora R.J., Lopez A.S.E., Gubari M.I.M., Koonrungsesomboon N., Takuathung M.N., Ruengorn C., Nochaiwong S., Kanjanarat P., Elhassan S.M., Dzhemiliev A., Olvera B.P.G., Haque M.A., Ullah I., Dajti I., Kërpaçi J., Vrapi E., Venkatesh U., Hassan Z., Ahmed Z.S., Alrahman M.F., Khanh T.T., Qarawi A.T.A., Kudlatska-Tyshko I., Ali I., Ng S.J., Nghia P.T., Pavlenko M., Abbas K.S., Omran H.A.M., Rezq C.S., Ibrahim M.I.A., Ragheb M.S., Monib F.A., Said A.E., Ahmed S.F., Hamed Z.H., Nageh M.A., Sayed E., Shibani M., Ismail A.H., Alzabibi M.A., Sawaf B., Chuah J., Lim Y.L., Jee Y.S., Hamed A.H.M., Miranda A.V., Kubota K., Aoki K., Gyanwali P., Dhimal M., Koirala P., Adhikari K., Lucas F., Ordóñez J.N.P., Aburto J.T.O., Chong L.C., Younes B., Pavlenko R., Iqtadar S., Ghani U., Mumtaz S.U., Khan A.A., TMGH-Global COVID-19 Collaborative |
57199622107;57218120041;57224078312;57224082661;57224089160;35321918400;57220065688;57224091973;57224072368;57224082619;57224095725;57218407158;56580399700;57224073089;57209480434;56216340000;57224070842;56622984700;57225749183;57224068325;57223975589;57224097004;57224087649;57222960525;57224071699;57224073174;57224086154;57224080363;57223283646;57204158719;57224068925;57224089935;57224081202;57210795029;56288783600;57224077120;53878308600;57189848094;22992871700;57224069299;57220175050;57224091480;57218448682;57211152020;57218993911;57224092581;57221615805;57218892210;57215818914;57225670959;57224080553;57224086420;57224096129;57224087241;57223368799;57223195386;57224069007;57224069023;57223185385;57224095939;57224089287;57224086484;57224099028;57219123965;57222138764;57224098010;57224076675;57224090223;57224097163;57219773848;57224091545;57219774505;57195679503;57224073773;57224092806;57224072085;57224070356;57222664687;57201680054;57224094037;57194476849;54941157300;57224089702;56339701500;57224080691;57224090794;57224082163;57224092414;57224079470;56594973400;37661545300;57224097377;57224079051;57224093195; |
Psychological impacts and post-traumatic stress disorder among people under COVID-19 quarantine and isolation: A global survey |
2021 |
International Journal of Environmental Research and Public Health |
18 |
11 |
5719 |
|
|
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85106936924&doi=10.3390%2fijerph18115719&partnerID=40&md5=843d98405f6225b81732a50db6f59ae0 |
Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam; Faculty of Medicine, University of Gezira, Wad Medani, Sudan; Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam; Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal; Faculty of Medicine, South Valley University, Qena, Egypt; Department of Infectious Disease, Hanoi Medical University, Hanoi, Viet Nam; Traditional Medicine Hospital, Ministry of the Public Security, Hanoi, Viet Nam; Southern Adelaide Local Health Network, Adelaide, Australia; Rajarshee Chhatrapati Shahu Maharaj Govt Medical College, Kolhapur, India; Infectious Disease Hospital, Kano, Nigeria; National Hospital of Traditional Medicine, Hanoi, Viet Nam; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan; Ministry of Health and Population, Kathmandu, Nepal; Institute of Medicine, Tribhuvan University, Kathmandu, Nepal; Faculty of medicine, University of Tours, Tours, France; Faculty of Medicine, Menoufia University, Menoufia, Egypt; Medical Laboratory Science, College of Health Sciences, University of Human Development, Sulaymaniyah, Kurdistan region, Iraq; Baxshin Research Center, Baxshin Hospital, Sulaymaniyah, Kurdistan Region, Iraq; Health Emergency Management Bureau, Department of Health, Manila, Philippines; Faculty of Medicine, University of Tripoli, Tripoli, Libyan Arab Jamahiriya; Baxshin Research Center, Baxshin Hospital, Sulaymaniyah, Kurdistan region, Iraq; Faculty of Medicine, Trisakti University, Jakarta, Indonesia; America Evangelical University, Los Angeles, CA, United States; Yadika General Hospital, Jakarta, Indonesia; School of Medicine, Centro Escolar University, Manila, Philippines; Department of Ophthalmology, Bogomolets National Medical University, Kyiv, Ukraine; Department of Psychiatry, Mental Health Center, Awesar Medical Building Sulaymaniyah, Kurdistan region, Iraq; Qilu Hospital, Shandong University, Jinan, Shandong, China; Faculty of Medicine, Pontificia Universidad Católica del Ecuador, Quito, Ecuador; Department of Family and Community Medicine, College of Medicine, University of Sulaimaniyah, Sulaimaniyah, Kurdistan Region, Iraq; Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; Faculty of Medicine, Alneelain University, Khartoum, Sudan; Shalimov National Institute of Surgery and Transplantology, Kyiv, Ukraine; Autonomous University of Mexico State, Toluca, Mexico; Department of Orthopedic Surgery, Yan an hospital affiliated to Kunming Medical University, Kunming, Yunnan, China; Kabir Medical College, Gandhara University, Peshawar, Pakistan; UHOG ‘Koço Gliozheni’, Tirana, Albania; Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India; Cardiology department, Lady Reading Hospital, Peshawar, Pakistan; Faculty of Medicine, Cairo University, Egypt; University of Bakhat alruda, Ed Dueim, Sudan; Faculty of Medicine, School of Medicine and Pharmacy, Da Nang University, Da Nang City, Viet Nam; Lower Westchester Medical Associates, P.C., Mount Vernon, NY, United States; Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine; Paraplegic Center, Hayatabad Peshawar, Pakistan; Department of Medicine, Crozer-Chester Medical Center, Upland, PA, United States; Faculty of Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Viet Nam; Kyiv City Pediatric Diagnostic Center, Kyiv, Ukraine; Faculty of Medicine, Alexandria University, Alexandria, Egypt; Faculty of Medicine, Assiut University, Assiut, Egypt; Faculty of Medicine, Syrian Private University, Damascus, Syrian Arab Republic; School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia; Faculty of Medicine, Cairo University, Cairo, Egypt; Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Department of Biostatistics, Yokohama City University, Yokohama, Japan; Graduate School of Nursing, Chiba University, Chiba, Japan; Nepal Health Research Council, Kathmandu, Nepal; Faculty of Medicine, University of Lisbon, Lisbon, Portugal; Faculty of Medicine, Catholic University of Honduras, Honduras; Faculty of Medicine, Universidad de La Frontera, Temuco, Chile; School of Data Sciences, Perdana University, Kuala Lumpur, Malaysia; Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakesh, Morocco; Bogomolets National Medical University, Kyiv, Ukraine; King Edward Medical University, Lahore, Pakistan; Directorate General Health Services, Lahore, Pakistan; North Medical Ward, KEMU/Mayo Hospital, Lahore, Pakistan; Khyber Teaching Hospital, Peshawar, Pakistan |
Duc, N.T.M., Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam; Loc, L.Q., Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam; Alhady, S.T.M., Faculty of Medicine, University of Gezira, Wad Medani, Sudan; Sabir, D.M.E., Faculty of Medicine, University of Gezira, Wad Medani, Sudan; Mai, L.N., Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam; Dumre, S.P., Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal; Hassan, A.K., Faculty of Medicine, South Valley University, Qena, Egypt; Giang, T.V., Department of Infectious Disease, Hanoi Medical University, Hanoi, Viet Nam; Thach, P.N., Department of Infectious Disease, Hanoi Medical University, Hanoi, Viet Nam; Truong, L.V., Traditional Medicine Hospital, Ministry of the Public Security, Hanoi, Viet Nam; Ravikulan, R., Southern Adelaide Local Health Network, Adelaide, Australia; Raut, A., Rajarshee Chhatrapati Shahu Maharaj Govt Medical College, Kolhapur, India; Dayyab, F.M., Infectious Disease Hospital, Kano, Nigeria; Trang, V.T.T., National Hospital of Traditional Medicine, Hanoi, Viet Nam; Huy, N.T., School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan; Imoto, A., School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan; Dumre, R.B., School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan; Ranabhat, K., Ministry of Health and Population, Kathmandu, Nepal, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal; Sharma, G.N., Ministry of Health and Population, Kathmandu, Nepal; Habaj, N.A., Faculty of medicine, University of Tours, Tours, France; Elnoamany, S., Faculty of Medicine, Menoufia University, Menoufia, Egypt; Aziz, J.M.A., Medical Laboratory Science, College of Health Sciences, University of Human Development, Sulaymaniyah, Kurdistan region, Iraq, Baxshin Research Center, Baxshin Hospital, Sulaymaniyah, Kurdistan Region, Iraq; Crispino, K.T., Health Emergency Management Bureau, Department of Health, Manila, Philippines; Alsuwiyah, S., Faculty of Medicine, University of Tripoli, Tripoli, Libyan Arab Jamahiriya; Hussein, R.M., Baxshin Research Center, Baxshin Hospital, Sulaymaniyah, Kurdistan region, Iraq; Hama, D.J., Baxshin Research Center, Baxshin Hospital, Sulaymaniyah, Kurdistan region, Iraq; Morena, G.J.V., Faculty of Medicine, Trisakti University, Jakarta, Indonesia, America Evangelical University, Los Angeles, CA, United States; Aritonang, R.S., Faculty of Medicine, Trisakti University, Jakarta, Indonesia, Yadika General Hospital, Jakarta, Indonesia; Rocha, I.C.N., School of Medicine, Centro Escolar University, Manila, Philippines; Pavlenko, D., Department of Ophthalmology, Bogomolets National Medical University, Kyiv, Ukraine; Kareem, H.F.H., Department of Psychiatry, Mental Health Center, Awesar Medical Building Sulaymaniyah, Kurdistan region, Iraq; Antora, R.J., Qilu Hospital, Shandong University, Jinan, Shandong, China; Lopez, A.S.E., Faculty of Medicine, Pontificia Universidad Católica del Ecuador, Quito, Ecuador; Gubari, M.I.M., Department of Family and Community Medicine, College of Medicine, University of Sulaimaniyah, Sulaimaniyah, Kurdistan Region, Iraq; Koonrungsesomboon, N., Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Takuathung, M.N., Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Ruengorn, C., Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; Nochaiwong, S., Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; Kanjanarat, P., Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; Elhassan, S.M., Faculty of Medicine, Alneelain University, Khartoum, Sudan; Dzhemiliev, A., Shalimov National Institute of Surgery and Transplantology, Kyiv, Ukraine; Olvera, B.P.G., Autonomous University of Mexico State, Toluca, Mexico; Haque, M.A., Department of Orthopedic Surgery, Yan an hospital affiliated to Kunming Medical University, Kunming, Yunnan, China; Ullah, I., Kabir Medical College, Gandhara University, Peshawar, Pakistan; Dajti, I., UHOG ‘Koço Gliozheni’, Tirana, Albania; Kërpaçi, J., UHOG ‘Koço Gliozheni’, Tirana, Albania; Vrapi, E., UHOG ‘Koço Gliozheni’, Tirana, Albania; Venkatesh, U., Department of Community Medicine, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India; Hassan, Z., Cardiology department, Lady Reading Hospital, Peshawar, Pakistan; Ahmed, Z.S., Faculty of Medicine, Cairo University, Egypt; Alrahman, M.F., University of Bakhat alruda, Ed Dueim, Sudan; Khanh, T.T., Faculty of Medicine, School of Medicine and Pharmacy, Da Nang University, Da Nang City, Viet Nam; Qarawi, A.T.A., Lower Westchester Medical Associates, P.C., Mount Vernon, NY, United States; Kudlatska-Tyshko, I., Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine; Ali, I., Paraplegic Center, Hayatabad Peshawar, Pakistan; Ng, S.J., Department of Medicine, Crozer-Chester Medical Center, Upland, PA, United States; Nghia, P.T., Faculty of Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Viet Nam; Pavlenko, M., Kyiv City Pediatric Diagnostic Center, Kyiv, Ukraine; Abbas, K.S., Faculty of Medicine, Alexandria University, Alexandria, Egypt; Omran, H.A.M., Faculty of Medicine, Alexandria University, Alexandria, Egypt; Rezq, C.S., Faculty of Medicine, Alexandria University, Alexandria, Egypt; Ibrahim, M.I.A., Faculty of Medicine, Alexandria University, Alexandria, Egypt; Ragheb, M.S., Faculty of Medicine, Alexandria University, Alexandria, Egypt; Monib, F.A., Faculty of Medicine, Assiut University, Assiut, Egypt; Said, A.E., Faculty of Medicine, Assiut University, Assiut, Egypt; Ahmed, S.F., Faculty of Medicine, Assiut University, Assiut, Egypt; Hamed, Z.H., Faculty of Medicine, Assiut University, Assiut, Egypt; Nageh, M.A., Faculty of Medicine, Assiut University, Assiut, Egypt; Sayed, E., Faculty of Medicine, Assiut University, Assiut, Egypt; Shibani, M., Faculty of Medicine, Syrian Private University, Damascus, Syrian Arab Republic; Ismail, A.H., Faculty of Medicine, Syrian Private University, Damascus, Syrian Arab Republic; Alzabibi, M.A., Faculty of Medicine, Syrian Private University, Damascus, Syrian Arab Republic; Sawaf, B., Faculty of Medicine, Syrian Private University, Damascus, Syrian Arab Republic; Chuah, J., School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia; Lim, Y.L., School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia; Jee, Y.S., School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia; Hamed, A.H.M., Faculty of Medicine, Cairo University, Cairo, Egypt; Miranda, A.V., Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Kubota, K., Department of Biostatistics, Yokohama City University, Yokohama, Japan; Aoki, K., Graduate School of Nursing, Chiba University, Chiba, Japan; Gyanwali, P., Nepal Health Research Council, Kathmandu, Nepal; Dhimal, M., Nepal Health Research Council, Kathmandu, Nepal; Koirala, P., Nepal Health Research Council, Kathmandu, Nepal; Adhikari, K., Nepal Health Research Council, Kathmandu, Nepal; Lucas, F., Faculty of Medicine, University of Lisbon, Lisbon, Portugal; Ordóñez, J.N.P., Faculty of Medicine, Catholic University of Honduras, Honduras; Aburto, J.T.O., Faculty of Medicine, Universidad de La Frontera, Temuco, Chile; Chong, L.C., School of Data Sciences, Perdana University, Kuala Lumpur, Malaysia; Younes, B., Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakesh, Morocco; Pavlenko, R., Bogomolets National Medical University, Kyiv, Ukraine; Iqtadar, S., King Edward Medical University, Lahore, Pakistan; Ghani, U., Directorate General Health Services, Lahore, Pakistan; Mumtaz, S.U., North Medical Ward, KEMU/Mayo Hospital, Lahore, Pakistan; Khan, A.A., Khyber Teaching Hospital, Peshawar, Pakistan; TMGH-Global COVID-19 Collaborative |
Understanding the presence of post-traumatic stress disorder (PTSD) symptoms in quarantined/ isolated individuals is essential for decreasing morbidity and mortality caused by the COVID-19 pandemic. However, there is a paucity of evidence quantifying PTSD status globally during confinement in quarantine/isolation facilities during COVID-19. Therefore, we aimed to assess the PTSD status and factors contributing to PTSD development in quarantined/isolated people during pandemic. Using the Impact of Event Scale-Revised (IES-R) scale, our multicentre, multinational, and cross-sectional online survey assessed the psychological impacts on the quarantine/isolation experience of participants suspected or confirmed to have COVID-19, their PTSD status, and various correlates with developing PTSD. We had 944 (35.33%) valid responses (51.1% from females), mostly from Asian countries (635, 71.4%), and 33.9% were healthcare workers. The number of quarantine days in the PTSD symptoms group (using the IES-R cutoff of 24 for symptomatic or full PTSD) was significantly shorter compared to the non-PTSD group (14 (range 14-40) vs. 14 (14-23.75), p = 0.031). Lower rates of PTSD symptoms were observed in participants practicing Buddhist religion than in participants having no religion (OR: 0.30; 95% CI: 0.13-0.68; p = 0.005); individuals with vocational training had a higher risk of developing PTSD symptoms (OR: 2.28 (1.04-5.15); p = 0.043) compared to university graduates. Individuals forced to be quarantined/isolated had higher odds of developing PTSD symptoms than those voluntarily quarantined/isolated (OR: 2.92 (1.84-4.74); p < 0.001). We identified several PTSD correlations among individuals quarantined/isolated during the COVID-19 pandemic, including religious practice, reason for quarantine/isolation, education level, and being a case of the infection. These findings can inform worldwide policies to minimize the adverse effects of such social control measures. © 2021 by the author. |
COVID-19; Global survey; Impact of event-scale; Isolation; Mental health; Pandemic; PTSD; Quarantine |
COVID-19; developing world; epidemiology; health worker; mental disorder; psychology; religion; survey method; adult; Article; Asian; controlled study; coronavirus disease 2019; cross-sectional study; female; health care personnel; health survey; human; Impact of Events Scale; major clinical study; male; mental health; multicenter study; pandemic; patient isolation; posttraumatic stress disorder; psychological aspect; quarantine; questionnaire; religion; symptom; vocational education |
MDPI |
16617827 |
|
34073524 |
Article |
Q2 |
747 |
6560 |
|
|
|
541 |
Fujiwara T., Hoshide S., Tomitani N., Cheng H.-M., Soenarta A.A., Turana Y., Chen C.-H., Minh H.V., Sogunuru G.P., Tay J.C., Wang T.-D., Chia Y.-C., Verma N., Li Y., Wang J.-G., Kario K. |
57212076752;6603859769;57189644362;57026688600;6507634613;56083326000;7501963868;57211946145;26428524900;24330212600;7405566618;57204080905;7102496979;55931488300;57211730247;7102633390; |
Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
457 |
466 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101488308&doi=10.1111%2fjch.14218&partnerID=40&md5=d3540818497da0e2ae884c08bf5b5ad6 |
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Faculty of Medical and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Department of Cardiology, MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Physiology, King George's Medical University, Lucknow, India; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China |
Fujiwara, T., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Tomitani, N., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Cheng, H.-M., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Turana, Y., Faculty of Medical and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Chen, C.-H., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Minh, H.V., Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Sogunuru, G.P., Department of Cardiology, MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Verma, N., Department of Physiology, King George's Medical University, Lucknow, India; Li, Y., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan |
Nocturnal home blood pressure (BP) monitoring has been used in clinical practice for ~20 years. The authors recently showed that nocturnal systolic BP (SBP) measured by a home BP monitoring (HBPM) device in a Japanese general practice population was a significant predictor of incident cardiovascular disease (CVD) events, independent of office and morning home SBP levels, and that masked nocturnal hypertension obtained by HBPM (defined as nocturnal home BP ≥ 120/70 mmHg and average morning and evening BP < 135/85 mmHg) was associated with an increased risk of CVD events compared with controlled BP (nocturnal home BP < 120/70 mmHg and average morning and evening BP < 135/85 mmHg). This evidence revealed that (a) it is feasible to use a nocturnal HBPM device for monitoring nocturnal BP levels, and (b) such a device may offer an alternative to ambulatory BP monitoring, which has been the gold standard for the measurement of nocturnal BP. However, many unresolved clinical problems remain, such as the measurement schedule and conditions for the use of nocturnal HBPM. Further investigation of the measurement of nocturnal BP using an HBPM device and assessments of the prognostic value are thus warranted. Asians are at high risk of developing nocturnal hypertension due to high salt sensitivity and salt intake, and the precise management of their nocturnal BP levels is important. Information and communication technology-based monitoring devices are expected to facilitate the management of nocturnal hypertension in Asian populations. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC |
Asia; blood pressure; blood pressure monitoring; nocturnal home blood pressure; nocturnal hypertension |
albumin to creatinine ratio; Asia; blood pressure measurement; blood pressure monitoring; blood pressure regulation; cardiovascular disease; clinical feature; clinical research; diagnostic value; feasibility study; general practice; gold standard; high risk population; human; hypertension; Japanese (people); medical informatics; nocturnal home blood pressure monitoring; nocturnal hypertension; organ injury; pathophysiology; prognosis; Review; salt intake; systolic blood pressure; target organ damage; blood pressure; blood pressure monitoring; hypertension; masked hypertension; Asia; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Masked Hypertension |
John Wiley and Sons Inc |
15246175 |
|
33591641 |
Review |
Q2 |
909 |
5078 |
|
|
|
547 |
Tsoi K., Yiu K., Lee H., Cheng H.-M., Wang T.-D., Tay J.-C., Teo B.W., Turana Y., Soenarta A.A., Sogunuru G.P., Siddique S., Chia Y.-C., Shin J., Chen C.-H., Wang J.-G., Kario K., the HOPE Asia Network |
16065259000;24167446900;57271749300;57026688600;7405566618;24330212600;23570166200;56083326000;6507634613;26428524900;57210091066;57204080905;54791393300;7501963868;57211730247;7102633390; |
Applications of artificial intelligence for hypertension management |
2021 |
Journal of Clinical Hypertension |
23 |
3 |
|
568 |
574 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100377966&doi=10.1111%2fjch.14180&partnerID=40&md5=cdd3526a471a2db59f4ca490ffd9d59b |
SH Big Data Decision and Analytics Research Centre, Shatin, Hong Kong; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of Neurology, School of Medicine and health Sciences, Atma Jaya Catholic University of Indonesia, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Department of Cardiology, MIOT international hospital, Chennai, India; Punjab Medical Center, Lahore, Pakistan; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Faculty of Medicine, Department of Primary Care Medicine, University of Malaya, Kuala Lumpur, Malaysia; Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan |
Tsoi, K., SH Big Data Decision and Analytics Research Centre, Shatin, Hong Kong, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Yiu, K., SH Big Data Decision and Analytics Research Centre, Shatin, Hong Kong; Lee, H., JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong; Cheng, H.-M., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Tay, J.-C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Teo, B.W., Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore; Turana, Y., Department of Neurology, School of Medicine and health Sciences, Atma Jaya Catholic University of Indonesia, Indonesia; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Sogunuru, G.P., Department of Cardiology, MIOT international hospital, Chennai, India; Siddique, S., Punjab Medical Center, Lahore, Pakistan; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Faculty of Medicine, Department of Primary Care Medicine, University of Malaya, Kuala Lumpur, Malaysia; Shin, J., Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, South Korea; Chen, C.-H., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan; the HOPE Asia Network |
The prevalence of hypertension is increasing along with an aging population, causing millions of premature deaths annually worldwide. Low awareness of blood pressure (BP) elevation and suboptimal hypertension diagnosis serve as the major hurdles in effective hypertension management. The advent of artificial intelligence (AI), however, sheds the light of new strategies for hypertension management, such as remote supports from telemedicine and big data-derived prediction. There is considerable evidence demonstrating the feasibility of AI applications in hypertension management. A foreseeable trend was observed in integrating BP measurements with various wearable sensors and smartphones, so as to permit continuous and convenient monitoring. In the meantime, further investigations are advised to validate the novel prediction and prognostic tools. These revolutionary developments have made a stride toward the future model for digital management of chronic diseases. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. |
|
antihypertensive agent; antihypertensive therapy; artificial intelligence; blood pressure monitoring; blood pressure regulation; disease burden; feasibility study; health care cost; human; hypertension; incidence; lifestyle modification; mobile application; outcome assessment; prediction; prognosis; Review; telemedicine; trend study; validation process; aged; artificial intelligence; hypertension; telemedicine; Aged; Artificial Intelligence; Humans; Hypertension; Telemedicine |
John Wiley and Sons Inc |
15246175 |
|
33533536 |
Review |
Q2 |
909 |
5078 |
|
|
|
562 |
Hanafi E., Siste K., Limawan A.P., Sen L.T., Christian H., Murtani B.J., Adrian, Siswidiani L.P., Suwartono C. |
56737010600;55644113100;57202712511;57219034101;57209266195;57216652176;57216932703;57219029296;15078359800; |
Alcohol- and Cigarette-Use Related Behaviors During Quarantine and Physical Distancing Amid COVID-19 in Indonesia |
2021 |
Frontiers in Psychiatry |
12 |
|
622917 |
|
|
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100903075&doi=10.3389%2ffpsyt.2021.622917&partnerID=40&md5=eb7936d1479358e8922064492a38ba78 |
Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia |
Hanafi, E., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Siste, K., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Limawan, A.P., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Sen, L.T., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Christian, H., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Murtani, B.J., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Adrian, Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Siswidiani, L.P., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Suwartono, C., Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia |
Background: In light of the coronavirus disease 2019 (COVID-19) pandemic, Indonesia implemented large-scale social restrictions (pembatasan sosial berskala besar/PSBB) to combat the spread of COVID-19, which might influence addictive behaviors. The current study aimed to explore the fluctuation of substance use during the pandemic and association of physical distancing and related factors toward consumption of alcohol and cigarettes. Method: An online survey was conducted from April 28 to June 1, 2020. Data regarding sociodemographic information, physical distancing profile, alcohol and cigarette usages, Alcohol Use Disorders Identification Test (AUDIT), Cigarette Dependence Scale (CDS), Symptom Checklist-90, and Pittsburg Sleep Quality Index (PSQI) were collected. A total of 4,584 respondents from all 34 provinces in Indonesia completed the survey. Data were summarized descriptively and analyzed using chi-square, ANOVA, and multinomial regression on SPSS 23.0 for Windows. Results: This study found that during the COVID-19 pandemic in Indonesia alcohol consumption was 9.50% and daily cigarette smoking was 20.3%. Around 44.5% and 47.6% of respondents reported stable alcohol consumption and cigarette consumption, respectively. The mean AUDIT score was 3.52 ± 4.66 and the mean CDS score was 24.73 ± 8.86. Physical distancing was not correlated to any substance use changes. Increased alcohol consumption was negatively correlated with being unmarried and positively correlated with a higher PSQI score. Decreased alcohol use positively correlated with living in PSBB-implementing provinces and higher AUDIT scores when compared to stable alcohol drinking. Increased cigarette smoking was positively correlated with being male, unmarried, and higher CDS scores. Reduced cigarette smoking was negatively correlated with living in provinces implementing PSBB, higher CDS scores, and phobic anxiety, hostility, and psychoticism subscales of SCL-90. Discussion and Conclusion: The prevalence of alcohol and cigarette consumption changes showed a similar trend with other available studies in other countries. This study established that substance use was mainly sustained with a smaller proportion of respondents amplifying their substance usages. The changes were correlated with PSBB policy but not the practice of physical distancing. Psychiatry and addiction services in Indonesia should be strengthened to cope with the increased burden of psychological distress. Future studies should conduct more comparisons to determine whether the overall rising intensity of consumption was maintained post-pandemic and delineate acute psychopathologies' effects on substance use. © Copyright © 2021 Hanafi, Siste, Limawan, Sen, Christian, Murtani, Adrian, Siswidiani and Suwartono. |
alcohol; cigarette; large-scale social restriction; physical distancing; prevalence |
alcohol; addiction; adult; alcohol consumption; Alcohol Use Disorders Identification Test; alcoholism; analysis of variance; Article; chi square test; Cigarette Dependence Scale; cigarette smoking; controlled study; coronavirus disease 2019; demography; distress syndrome; drinking behavior; female; hostility; human; Indonesia; lockdown; major clinical study; male; mental disease; pandemic; phobia; Pittsburgh Sleep Quality Index; policy; prevalence; psychiatry; psychometry; psychosis; scoring system; sleep disorder; social distancing; social media; substance use; Symptom Checklist 90 |
Frontiers Media S.A. |
16640640 |
|
|
Article |
Q1 |
1363 |
2668 |
|
|
|
574 |
Khaedir Y., Kartika R. |
57210448725;57216548032; |
Perspectives on Targeting IL-6 as a Potential Therapeutic Strategy for COVID-19 |
2021 |
Journal of Interferon and Cytokine Research |
41 |
2 |
|
37 |
43 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101400819&doi=10.1089%2fjir.2020.0135&partnerID=40&md5=98ca5a1b9e49b8a60fe141024cc36031 |
Department of Histology, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia; Immunology, Master's Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia; Division of Metabolic, Endocrinology and Diabetes, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia |
Khaedir, Y., Department of Histology, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia, Immunology, Master's Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia; Kartika, R., Division of Metabolic, Endocrinology and Diabetes, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia |
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has been a major threat to global public health. In Indonesia, the cases have rapidly increased, and the case fatality rate remains high. With COVID-19, most of the deaths have been caused by acute respiratory distress syndrome and dysregulation of the immune response. A lung biopsy from a patient with COVID-19 showed inflammatory cellular infiltration with diffuse alveolar damage. Massive pulmonary destruction has also been reported as a result of highly increased levels of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1β, interferon-γ(IFN-γ), induced protein 10 (IP-10), and monocyte chemoattractant protein-1 (MCP-1). IL-6 is an inflammatory cytokine produced by various cell types, including immune cells and nonleukocytes, such as endothelial cells, fibroblasts, epithelial cells, type II pneumocytes, and certain tumor cells. Several studies have shown that IL-6 contributes to the severity and mortality of COVID-19. In this review, we would like to explore the immune response in COVID-19 and the role of IL-6 in the immunopathogenesis of COVID-19. © Copyright 2021, Mary Ann Liebert, Inc., publishers 2021. |
coronavirus disease 2019; immune response; interleukin-6 |
interleukin 6; tocilizumab; IL6 protein, human; interleukin 6; interleukin 6 receptor; JAK1 protein, human; JAK2 protein, human; Janus kinase 1; Janus kinase 2; Janus kinase inhibitor; monoclonal antibody; pyrazole derivative; ruxolitinib; sarilumab; tocilizumab; cell infiltration; clinical outcome; coronavirus disease 2019; cytokine storm; human; immune response; immunopathogenesis; lung alveolus cell; priority journal; prospective study; Review; Severe acute respiratory syndrome coronavirus 2; signal transduction; cytokine release syndrome; drug effect; immunology; Indonesia; pathology; respiratory distress syndrome; Antibodies, Monoclonal, Humanized; COVID-19; Cytokine Release Syndrome; Humans; Indonesia; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Janus Kinase Inhibitors; Pyrazoles; |
Mary Ann Liebert Inc. |
10799907 |
|
33621130 |
Review |
Q1 |
1031 |
4200 |
|
|
|
575 |
Fuady A., Houweling T.A.J., Richardus J.H. |
37085331400;10639726000;7003977198; |
Perspective piece COVID-19 and tuberculosis-related catastrophic costs |
2021 |
American Journal of Tropical Medicine and Hygiene |
104 |
2 |
|
436 |
440 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101400221&doi=10.4269%2fajtmh.20-1125&partnerID=40&md5=a3c370677fb6cad8407b4d92b3768798 |
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Fuady, A., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands, Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Houweling, T.A.J., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Richardus, J.H., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands |
The COVID-19 pandemic has created an unprecedented health crisis and a substantial socioeconomic impact. It also affects tuberculosis (TB) control severely worldwide. Interruptions of many TB control programs because of the COVID-19 pandemic could result in significant setbacks. One of the targets that can be affected is the WHO's End TB Strategy goal to eliminate catastrophic costs of TB-affected households by 2030. Disruptions to TB programs and healthcare services due to COVID-19 could potentially prolong diagnostic delays and worsen TB treatment adherence and outcomes. The economic recession caused by the pandemic could significantly impact household financial capacity because of the reduction of income and the rise in unemployment rates. All of these factors increase the risk of TB incidence and the gravity of economic impact on TB-affected households, and hamper efforts to eliminate catastrophic costs and control TB. Therefore, efforts to eliminate the incidence of TB-affected households facing catastrophic costs will be very challenging. Because financial constraint plays a significant role in TB control, the improvement of health and social protection systems is critical. Even before the pandemic, many TB-high-burden countries (HBCs) lacked robust health and social protection systems. These challenges highlight the substantial need for a more robust engagement of patients and civil society organizations and international support in addressing the consequences of COVID-19 on the control of TB. © 2021 by The American Society of Tropical Medicine and Hygiene. |
|
tuberculostatic agent; clinical outcome; coronavirus disease 2019; delayed diagnosis; disaster; disease burden; disease control; economic recession; financial management; health care cost; health program; health service; household; human; incidence; income; infection control; infection risk; organization; pandemic; patient compliance; Review; social aspect; social protection system; socioeconomics; tuberculosis; unemployment; World Health Organization; economics; family size; health care cost; tuberculosis; COVID-19; Family Characteristics; Health Care Costs; Humans; Incidence; Income; SARS-CoV-2; Tuberculosis |
American Society of Tropical Medicine and Hygiene |
00029637 |
|
33269683 |
Review |
Q1 |
1015 |
4298 |
|
|
|
828 |
Suryana K.D., Simadibrata M., Renaldi K. |
57222750873;23499598400;57190963547; |
Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges |
2021 |
Acta medica Indonesiana |
53 |
1 |
|
96 |
104 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103994291&partnerID=40&md5=8f9253303dd7921abe223346263c353b |
Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/ Dr. Cipto Mangunkusumo General Hospital National HospitalJakarta, Indonesia |
Suryana, K.D., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/ Dr. Cipto Mangunkusumo General Hospital National HospitalJakarta, Indonesia; Simadibrata, M.; Renaldi, K. |
SARS-CoV-2 is a virus that can enter its hosts through the Angiotensin Converting Enzyme-2 (ACE2) receptor. ACE2 is mainly expressed in cells of the gastrointestinal tract, such as the esophageal epithelium and enterocytes from the ileum-colon. Coronavirus Disease 2019 (COVID-19) has varying clinical symptoms and presents differently in individuals, ranging from asymptomatic carriers to moderate clinical spectrum with mild pneumonia clinical features, and to a severe clinical presentation with dyspnea and hypoxia, leading to death due to respiratory or multi-organ failure. COVID-19 infection can also manifest themselves in the form of gastrointestinal symptoms such as diarrhea, vomiting, nausea, and abdominal pain. Severe complications of gastrointestinal COVID-19 infections include hemorrhage or perforation of the gastrointestinal tract and severe inflammation, which can adversely affect the intestinal immune system, and therefore the systemic immune system of the host. Furthermore, COVID-19 has also shown to affect microbiota homeostasis in the digestive tract. To date, no clear explanation is available regarding the pathophysiology of gastrointestinal SARS-CoV-2 infection, fecal RNA detection, and the possibility of fecal-oral transmission of SARS-CoV-2. This review aims to discuss the effects of SARS-CoV-2 infection on the digestive tract, microbiota, and lung, and the possibility of fecal-oral transmission in COVID-19. |
Gastroenterology; Hepatology; Infection; Internal medicine; Pulmonology; Tropical disease |
feces; gastrointestinal disease; gastrointestinal tract; human; immunology; isolation and purification; pathogenicity; pathophysiology; physiology; prevention and control; virology; COVID-19; Feces; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; SARS-CoV-2 |
NLM (Medline) |
01259326 |
|
33818412 |
Review |
Q3 |
321 |
14162 |
|
|
|
847 |
Atmosudigdo I.S., Lim M.A., Radi B., Henrina J., Yonas E., Vania R., Pranata R. |
57222578186;57216039756;6603494019;57218482646;57201987097;57208328436;57201973901; |
Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression |
2021 |
Clinical Medicine Insights: Endocrinology and Diabetes |
14 |
|
|
|
|
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103239096&doi=10.1177%2f1179551421990675&partnerID=40&md5=f2529886c6cb74cf353635e1abd100c3 |
Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Balaraja General Hospital, Tangerang, Indonesia; Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Division of Plastic, Reconstructive and Aesthetic, Department of Surgery, Faculty of Medicine, Sanglah General Hospital, Udayana University, Bali, Indonesia |
Atmosudigdo, I.S., Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Lim, M.A., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Radi, B., Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Henrina, J., Balaraja General Hospital, Tangerang, Indonesia; Yonas, E., Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Vania, R., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia, Division of Plastic, Reconstructive and Aesthetic, Department of Surgery, Faculty of Medicine, Sanglah General Hospital, Udayana University, Bali, Indonesia; Pranata, R., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia |
Objective: This systematic review and meta-analysis aimed to evaluate whether dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate whether other comorbidities influence the association. Methods: A systematic literature search using PubMed, Embase, and EuropePMC was performed on 8 October 2020. This study’s main outcome is a poor composite outcome, comprising of mortality and severe COVID-19. Results: There were 9 studies with 3663 patients. The prevalence of dyslipidemia in this pooled analysis was 18% (4%-32%). Dyslipidemia was associated with increased composite poor outcome (RR 1.39 [1.02, 1.88], P =.010; I2: 56.7%, P =.018). Subgroup analysis showed that dyslipidemia was associated with severe COVID-19 (RR 1.39 [1.03, 1.87], P =.008; I2: 57.4%, P =.029). Meta-regression showed that the association between dyslipidemia and poor outcome varies by age (coefficient: −0.04, P =.033), male gender (coefficient: −0.03, P =.042), and hypertension (coefficient: −0.02, P =.033), but not diabetes (coefficient: −0.24, P =.135) and cardiovascular diseases (coefficient: −0.01, P =.506). Inverted funnel-plot was relatively symmetrical. Egger’s test indicates that the pooled analysis was not statistically significant for small-study effects (P =.206). Conclusion: Dyslipidemia potentially increases mortality and severity of COVID-19. The association was stronger in patients with older age, male, and hypertension. PROSPERO Registration Number: CRD42020213491 © The Author(s) 2021. |
coronavirus; COVID-19; dyslipidemia; hyperlipidemia; prognosis |
Article; comorbidity; coronavirus disease 2019; diabetes mellitus; disease association; disease severity; dyslipidemia; human; hypertension; infection risk; mortality; prevalence; prognosis; risk assessment; systematic review |
SAGE Publications Ltd |
11795514 |
|
|
Article |
Q3 |
527 |
9598 |
|
|
|
901 |
Kadosh K.C., Muhardi L., Parikh P., Basso M., Mohamed H.J.J., Prawitasari T., Samuel F., Ma G., Geurts J.M.W. |
12243251700;57216729101;35269493300;57221482131;41861368100;57190686255;14421774000;57199673360;57197926057; |
Nutritional support of neurodevelopment and cognitive function in infants and young children—an update and novel insights |
2021 |
Nutrients |
13 |
1 |
199 |
1 |
26 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099415887&doi=10.3390%2fnu13010199&partnerID=40&md5=9754b1ffd94e454fc9ae27ba058537af |
School of Psychology, University of Surrey, Guildford, GU2 7XH, United Kingdom; FrieslandCampina AMEA, Singapore, 039190, Singapore; Department of General Psychology, University of Padova, Padova, 35131, Italy; Nutrition and Dietetics Programme, School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Malaysia; Nutrition and Metabolic Diseases Working Group, Indonesian Pediatric Society, Jakarta, 10310, Indonesia; Department of Pediatrics, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusomo National Referral Hospital Jakarta, Jakarta, 10430, Indonesia; Department of Human Nutrition, University of Ibadan, Ibadan, 200284, Nigeria; Department of Nutrition and Food Hygiene, School of Public Health, Peking University, 38 Xue Yuan Road, Haidian District, Beijing, 10019, China; Laboratory of Toxicological Research and Risk assessment for Food Safety, Peking University, 38 Xue Yuan Road, Haidian District, Beijing, 100191, China; FrieslandCampina, Amersfoort, 3818 LE, Netherlands |
Kadosh, K.C., School of Psychology, University of Surrey, Guildford, GU2 7XH, United Kingdom; Muhardi, L., FrieslandCampina AMEA, Singapore, 039190, Singapore; Parikh, P., FrieslandCampina AMEA, Singapore, 039190, Singapore; Basso, M., School of Psychology, University of Surrey, Guildford, GU2 7XH, United Kingdom, Department of General Psychology, University of Padova, Padova, 35131, Italy; Mohamed, H.J.J., Nutrition and Dietetics Programme, School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Malaysia; Prawitasari, T., Nutrition and Metabolic Diseases Working Group, Indonesian Pediatric Society, Jakarta, 10310, Indonesia, Department of Pediatrics, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusomo National Referral Hospital Jakarta, Jakarta, 10430, Indonesia; Samuel, F., Department of Human Nutrition, University of Ibadan, Ibadan, 200284, Nigeria; Ma, G., Department of Nutrition and Food Hygiene, School of Public Health, Peking University, 38 Xue Yuan Road, Haidian District, Beijing, 10019, China, Laboratory of Toxicological Research and Risk assessment for Food Safety, Peking University, 38 Xue Yuan Road, Haidian District, Beijing, 100191, China; Geurts, J.M.W., FrieslandCampina, Amersfoort, 3818 LE, Netherlands |
Proper nutrition is crucial for normal brain and neurocognitive development. Failure to optimize neurodevelopment early in life can have profound long-term implications for both mental health and quality of life. Although the first 1000 days of life represent the most critical period of neurodevelopment, the central and peripheral nervous systems continue to develop and change throughout life. All this time, development and functioning depend on many factors, including adequate nutrition. In this review, we outline the role of nutrients in cognitive, emotional, and neural development in infants and young children with special attention to the emerging roles of polar lipids and high quality (available) protein. Furthermore, we discuss the dynamic nature of the gut-brain axis and the importance of microbial diversity in relation to a variety of outcomes, including brain maturation/function and behavior are discussed. Finally, the promising therapeutic potential of psychobiotics to modify gut microbial ecology in order to improve mental well-being is presented. Here, we show that the individual contribution of nutrients, their interaction with other micro-and macronutrients and the way in which they are organized in the food matrix are of crucial importance for normal neurocognitive development. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. |
Brain; Childhood; Gut-brain axis; Kynurenine; Minerals; Neurodevelopment; Polar lipids; Polyunsaturated fatty acids; Prebiotics; Probiotics; Protein quality; Tryptophan; Tyrosine; Vitamins |
amino acid; branched chain amino acid; cyanocobalamin; iodine; iron; lipid; long chain fatty acid; mammalian target of rapamycin complex 1; phenylalanine; polar lipid; polyunsaturated fatty acid; prebiotic agent; probiotic agent; retinol; trace element; tryptophan; tyrosine; unclassified drug; vitamin D; zinc; fatty acid; kynurenine; mineral; brain development; child; cognition; emotion; human; infant; infant nutrition; intestine flora; macronutrient; nerve cell differentiation; nonhuman; nutritional support; protein intake; protein quality; Review; brain; cognitive aging; food; growth, development and aging; preschool child; quality of life; Brain; Child, Preschool; Cognition; Cognitive Aging; Emotions; Fatty Acids; Food; Gastrointestinal Microbiome; Humans; Infant; Kynurenine; Minerals; |
MDPI AG |
20726643 |
|
33435231 |
Review |
Q1 |
1418 |
2497 |
|
|
|
926 |
Pranata R., Tondas A.E., Yonas E., Vania R., Yamin M., Chandra A., Siswanto B.B. |
57201973901;57211111907;57201987097;57208328436;23475706300;37025699200;14422648800; |
Differences in clinical characteristics and outcome of de novo heart failure compared to acutely decompensated chronic heart failure–systematic review and meta-analysis |
2021 |
Acta Cardiologica |
76 |
4 |
|
410 |
420 |
|
4 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083567065&doi=10.1080%2f00015385.2020.1747178&partnerID=40&md5=e965cfa89cbc748fb0b3f9ae692b173b |
Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Sriwijaya, Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia; Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, United States; Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia |
Pranata, R., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Tondas, A.E., Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Sriwijaya, Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia; Yonas, E., Faculty of Medicine, Universitas YARSI, Jakarta, Indonesia; Vania, R., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Yamin, M., Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Chandra, A., Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, United States; Siswanto, B.B., Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia |
Background: Recent evidence showed that the characteristics and outcome of those with de novo heart failure (HF) and acutely decompensated chronic heart failure (ADCHF) were different. We aimed to perform a comprehensive search on the clinical characteristics and outcome of patients with de novo HF and ADCHF. Methods: We performed a comprehensive search on de novo/new onset acute HF vs ADCHF from inception up until December 2019. Results: There were 38320 patients from 15 studies. De novo HF were younger and, had less prevalent hypertension, diabetes mellitus, ischaemic heart disease, chronic obstructive pulmonary disease, atrial fibrillation, and history of stroke/transient ischaemic attack compared to ADCHF. Five studies showed a lower NT-proBNP in de novo HF patients, while one study showed no difference. Valvular heart disease as aetiology of heart failure was less frequent in de novo HF, and upon sensitivity analysis, hypertensive heart disease was more frequent in de novo HF. As for precipitating factors, ACS (OR 2.42; I2:89%) was more frequently seen in de novo HF, whereas infection was less frequently (OR 0.69; I2:32%) in ADCHF. De novo HF was associated with a significantly lower 3-month mortality (OR 0.63; I2:91%) and 1-year (OR 0.59; I2:59%) mortality. Meta-regression showed that 1-year mortality did not significantly vary with age (p =.106), baseline ejection fraction (p =.703), or HF reduced ejection fraction (p =.262). Conclusion: Risk factors, aetiology, and precipitating factors of HF in de novo and ADCHF differ. De novo HF also had lower 1-year mortality and 3-month mortality compared to ADCHF. © 2020 Belgian Society of Cardiology. |
acute decompensated heart failure; acute heart failure; characteristics; De novo heart failure; mortality; new onset heart failure |
amino terminal pro brain natriuretic peptide; creatinine; hemoglobin; acute coronary syndrome; acutely decompensated chronic heart failure; Article; atrial fibrillation; cardiovascular infection; cardiovascular mortality; cerebrovascular accident; Charlson Comorbidity Index; chronic obstructive lung disease; clinical feature; clinical outcome; coronary artery disease; de novo heart failure; diabetes mellitus; estimated glomerular filtration rate; heart arrhythmia; heart ejection fraction; heart failure; heart failure with reduced ejection fraction; hospital mortality; human; hypertension; ischemic heart disease; meta analysis; mortality rate; prevalence; risk factor; sensitivity analysis; smoking; systematic review; transient ischemic attack; valvular heart disease |
Taylor and Francis Ltd. |
00015385 |
|
32252602 |
Article |
Q3 |
348 |
13410 |
|
|
